• PharmaResearch and related parties’ voting stake in Pharma Research Bio rose to 61.34% from 50.08%, per an Oct. 29, 2026, disclosure.
• Total holdings fell to 62.02% from 63.67%, totaling 3,508,641 shares and other equity interests.
• Conversion of convertible bonds on Oct. 22 added 1,374,081 voting shares to PharmaResearch’s holdings.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharma Research Bio Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261029000468), on October 29, 2026, and is solely responsible for the information contained therein.